128 related articles for article (PubMed ID: 36809932)
1. Examining the Role of Histaminergic, Orexinergic, and Cannabinergic Systems in Redox Regulation in Gastric Adenocarcinoma.
Torres-Román AL; Rodríguez-Flores KL; Hernández-Mora VM; Ruiz-García E; Prospero-García O; Guijosa A; Molina A; Morales-Mulia M; Aschner M; Santamaría A; Ortega-Gómez A
Mini Rev Med Chem; 2023; 23(18):1806-1817. PubMed ID: 36809932
[TBL] [Abstract][Full Text] [Related]
2. Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H
Yamamoto K; Okui R; Yamatodani A
Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):925-936. PubMed ID: 30919010
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Börner C; Smida M; Höllt V; Schraven B; Kraus J
J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
[TBL] [Abstract][Full Text] [Related]
6. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation.
Braile M; Cristinziano L; Marcella S; Varricchi G; Marone G; Modestino L; Ferrara AL; De Ciuceis A; Scala S; Galdiero MR; Loffredo S
J Leukoc Biol; 2021 Mar; 109(3):621-631. PubMed ID: 32573828
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.
Cenni G; Blandina P; Mackie K; Nosi D; Formigli L; Giannoni P; Ballini C; Della Corte L; Mannaioni PF; Passani MB
Eur J Neurosci; 2006 Sep; 24(6):1633-44. PubMed ID: 17004927
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
Donadelli M; Dando I; Zaniboni T; Costanzo C; Dalla Pozza E; Scupoli MT; Scarpa A; Zappavigna S; Marra M; Abbruzzese A; Bifulco M; Caraglia M; Palmieri M
Cell Death Dis; 2011 Apr; 2(4):e152. PubMed ID: 21525939
[TBL] [Abstract][Full Text] [Related]
9. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.
Wei Y; Wang X; Wang L
Mol Vis; 2009 Jun; 15():1243-51. PubMed ID: 19547718
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
Ribeiro R; Wen J; Li S; Zhang Y
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.
Dando I; Donadelli M; Costanzo C; Dalla Pozza E; D'Alessandro A; Zolla L; Palmieri M
Cell Death Dis; 2013 Jun; 4(6):e664. PubMed ID: 23764845
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
[TBL] [Abstract][Full Text] [Related]
13. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
[TBL] [Abstract][Full Text] [Related]
14. Benzyl Isothiocyanate Induces Apoptosis via Reactive Oxygen Species-Initiated Mitochondrial Dysfunction and DR4 and DR5 Death Receptor Activation in Gastric Adenocarcinoma Cells.
Han KWW; Po WW; Sohn UD; Kim HJ
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817791
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
Mukhopadhyay P; Rajesh M; Pan H; Patel V; Mukhopadhyay B; Bátkai S; Gao B; Haskó G; Pacher P
Free Radic Biol Med; 2010 Feb; 48(3):457-67. PubMed ID: 19969072
[TBL] [Abstract][Full Text] [Related]
16. Activation of cannabinoid type 2 receptor protects skeletal muscle from ischemia-reperfusion injury partly via Nrf2 signaling.
Zhang M; Zhang M; Wang L; Yu T; Jiang S; Jiang P; Sun Y; Pi J; Zhao R; Guan D
Life Sci; 2019 Aug; 230():55-67. PubMed ID: 31128135
[TBL] [Abstract][Full Text] [Related]
17. Orexin A upregulates the protein expression of OX1R and enhances the proliferation of SGC-7901 gastric cancer cells through the ERK signaling pathway.
Liu Y; Zhao Y; Ju S; Guo L
Int J Mol Med; 2015 Feb; 35(2):539-45. PubMed ID: 25515760
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
Greenhough A; Patsos HA; Williams AC; Paraskeva C
Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
[TBL] [Abstract][Full Text] [Related]
19. The influence of mast cell mediators on migration of SW756 cervical carcinoma cells.
Rudolph MI; Boza Y; Yefi R; Luza S; Andrews E; Penissi A; Garrido P; Rojas IG
J Pharmacol Sci; 2008 Feb; 106(2):208-18. PubMed ID: 18296861
[TBL] [Abstract][Full Text] [Related]
20. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.
Henriquez JE; Crawford RB; Kaminski NE
Toxicol Appl Pharmacol; 2019 Apr; 369():82-89. PubMed ID: 30807757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
